HIV-1 Drug Resistance Genotype Results in Patients With Plasma Samples With HIV-1 RNA Levels Less Than 75 Copies/mL

Documenti analoghi

• N88D Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug Resistance in HIV Type 1 Protease following Nelfinavir Treatment Failure
  di: MITSUYA, YUMI, et al.
  Pubblicazione: (2006)
• HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance
  di: Rhee, Soo-Yon, et al.
  Pubblicazione: (2005)
• Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with Past Treatment
  di: Mitsuya, Yumi, et al.
  Pubblicazione: (2007)
• Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences
  di: Rhee, Soo-Yon, et al.
  Pubblicazione: (2018)
• Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms
  di: Rhee, Soo-Yon, et al.
  Pubblicazione: (2009)